Ishita Drugs and Industries Limited (BOM:524400)

Market Cap	217.10M -11.7%
Revenue (ttm)	161.68M +8.3%
Net Income	8.89M +3.1%
EPS	2.97 +3.1%
Shares Out	2.99M
PE Ratio	24.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,293
Average Volume	821
Open	74.90
Previous Close	73.99
Day's Range	71.00 - 74.90
52-Week Range	62.35 - 90.85
Beta	-0.59
RSI	50.53
Earnings Date	Feb 7, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1992
• Employees: 14
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524400

Financial Performance

In fiscal year 2025, BOM:524400's revenue was 149.97 million, a decrease of -1.25% compared to the previous year's 151.88 million. Earnings were 8.68 million, an increase of 15.98%.